Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company provides mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2017, the company operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in the United States, the United Kingdom, and Puerto Rico. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone615-861-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.01 billion
Profitability
Miscellaneous
Employees42,100
Next Earnings Date4/30/2019 (Confirmed)
OptionableOptionable
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare Company Inc (NASDAQ:ACHC) announced its earnings results on Thursday, February, 28th. The company reported $0.47 earnings per share for the quarter, hitting analysts' consensus estimates of $0.47. The business earned $743.55 million during the quarter, compared to the consensus estimate of $743.05 million. Acadia Healthcare had a negative net margin of 5.83% and a positive return on equity of 7.54%. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
How can I listen to Acadia Healthcare's earnings call?
Acadia Healthcare will be holding an earnings conference call on Wednesday, May 1st at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has Acadia Healthcare issued on next quarter's earnings?
Acadia Healthcare issued an update on its first quarter 2019 earnings guidance on Thursday, February, 28th. The company provided EPS guidance of $0.35-0.36 for the period, compared to the Thomson Reuters consensus estimate of $0.50. Acadia Healthcare also updated its FY 2019 guidance to $2.15-2.30 EPS.
What price target have analysts set for ACHC?
10 brokers have issued 12 month target prices for Acadia Healthcare's shares. Their forecasts range from $27.00 to $45.00. On average, they expect Acadia Healthcare's share price to reach $38.00 in the next twelve months. This suggests a possible upside of 19.6% from the stock's current price. View Analyst Price Targets for Acadia Healthcare.
What is the consensus analysts' recommendation for Acadia Healthcare?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare has been able to grow its top line on the back of organic and inorganic growth initiatives. The company has been actively emphasizing on acquisitions for expedited growth. Moreover, it is well positioned to fund its new bed development. The company’s robust balance sheet also impresses. However, its long-term debt has increased consistently for the past many years, leading to an increase in interest expense. The company has been witnessing rising expenses since 2009 inducing margin contraction. Shares of the company have lost in a year's time, comparing unfavorably with the industry's gain in the same time frame. A Zacks Rank #2 and an earnings ESP of 0.00% leave us inconclusive of an earnings surprise as it reports its fourth-quarter earnings on February 28." (2/18/2019)
- 2. Cantor Fitzgerald analysts commented, "We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions." (11/16/2018)
Has Acadia Healthcare been receiving favorable news coverage?
Media headlines about ACHC stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Acadia Healthcare earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
Who are some of Acadia Healthcare's key competitors?
Some companies that are related to Acadia Healthcare include TERUMO CORP/ADR (TRUMY), Steris (STE), Cochlear (COH), Genmab A/S (GNMSF), DexCom (DXCM), Ionis Pharmaceuticals (IONS), Sartorius (SRT), Henry Schein (HSIC), BioMerieux (BMXMF), Aurora Cannabis (ACB), Alnylam Pharmaceuticals (ALNY), Bio-Rad Laboratories (BIO.B), Davita (DVA), Bio-Rad Laboratories (BIO) and Qiagen (QGEN).
What other stocks do shareholders of Acadia Healthcare own?
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Mr. William Brent Turner, Pres (Age 53)
- Mr. David M. Duckworth, CFO, Chief Accounting Officer & Controller (Age 39)
- Mr. Ronald Morgon Fincher, Chief Operating Officer (Age 66)
- Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 52)
- Ms. Debra K. Osteen, CEO & Director (Age 63)
Who are Acadia Healthcare's major shareholders?
Acadia Healthcare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Skyline Asset Management LP (0.29%), Retirement Systems of Alabama (0.13%), BB&T Corp (0.07%), Tibra Equities Europe Ltd (0.03%), Cumberland Advisors Inc. (0.03%) and Brinker Capital Inc. (0.02%). Company insiders that own Acadia Healthcare stock include Brent Turner, Christopher L Howard, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger and William Grieco. View Institutional Ownership Trends for Acadia Healthcare.
Which institutional investors are selling Acadia Healthcare stock?
Which institutional investors are buying Acadia Healthcare stock?
ACHC stock was acquired by a variety of institutional investors in the last quarter, including Tibra Equities Europe Ltd, BB&T Corp, Brinker Capital Inc., Cumberland Advisors Inc. and Retirement Systems of Alabama. View Insider Buying and Selling for Acadia Healthcare.
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $31.76.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $2.81 billion and generates $3.01 billion in revenue each year. The company earns $-175,750,000.00 in net income (profit) each year or $2.24 on an earnings per share basis. Acadia Healthcare employs 42,100 workers across the globe.
What is Acadia Healthcare's official website?
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (NASDAQ ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
